Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score.
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: October 25, 2022
Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: December 23, 2021
Preoperative cognitive screening and brain health initiatives.
Journal: International anesthesiology clinics
Published: December 13, 2021
Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: December 06, 2021
Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities.
Journal: The Journal of infectious diseases
Published: October 05, 2021
Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: September 18, 2021
Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant.
Journal: Mayo Clinic proceedings
Published: September 01, 2021
Clinical Prioritization of Antispike Monoclonal Antibody Treatment of Mild to Moderate COVID-19.
Journal: Mayo Clinic proceedings
Published: August 26, 2021
Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome.
Journal: Journal of primary care & community health
Published: July 07, 2021
Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.
Journal: EClinicalMedicine
Published: July 05, 2021
Ginseng for the Treatment of Chronic Fatigue Syndrome: A Systematic Review of Clinical Studies.
Journal: Global advances in health and medicine
Published: July 02, 2021
Last Updated: 09/26/2026